These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 588557)

  • 21. Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.
    Salem HH; Esmon NL; Esmon CT; Majerus PW
    J Clin Invest; 1984 Apr; 73(4):968-72. PubMed ID: 6323539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a membrane protease from rat submaxillary-gland mitochondria that possess thrombin-like activity.
    Bharadwaj M; Bharadwaj D; Hati RN
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):193-9. PubMed ID: 8546683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+ dependence of the interactions between protein C, thrombin, and the elastase fragment of thrombomodulin. Analysis by ultracentrifugation.
    Olsen PH; Esmon NL; Esmon CT; Laue TM
    Biochemistry; 1992 Jan; 31(3):746-54. PubMed ID: 1310045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and characterization of haemathrins, madanin-like thrombin inhibitors, isolated from the salivary gland of tick Haemaphysalis bispinosa (Acari: Ixodidae).
    Brahma RK; Blanchet G; Kaur S; Manjunatha Kini R; Doley R
    Thromb Res; 2017 Apr; 152():20-29. PubMed ID: 28213103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
    Mesters RM; Heeb MJ; Griffin JH
    Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
    Gallistl S; Muntean W
    Thromb Haemost; 1994 Sep; 72(3):387-92. PubMed ID: 7855789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation.
    Ramjee MK
    Anal Biochem; 2000 Jan; 277(1):11-8. PubMed ID: 10610684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of platelet-rich plasma using thrombin receptor agonist peptide.
    Landesberg R; Burke A; Pinsky D; Katz R; Vo J; Eisig SB; Lu HH
    J Oral Maxillofac Surg; 2005 Apr; 63(4):529-35. PubMed ID: 15789326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin induces broad spectrum proteolysis in human serum samples.
    O'Mullan P; Craft D; Yi J; Gelfand CA
    Clin Chem Lab Med; 2009; 47(6):685-93. PubMed ID: 19099528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of a specific bond in troponin C by thrombin.
    Leavis PC; Rosenfeld S; Lu RC
    Biochim Biophys Acta; 1978 Aug; 535(2):281-6. PubMed ID: 678552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-function relationships of the thrombin-thrombomodulin interaction.
    Sadler JE; Lentz SR; Sheehan JP; Tsiang M; Wu Q
    Haemostasis; 1993 Mar; 23 Suppl 1():183-93. PubMed ID: 8388351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY
    Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin.
    Seiffert D; Loskutoff DJ
    Biochim Biophys Acta; 1991 May; 1078(1):23-30. PubMed ID: 1710930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation.
    Prasa D; Svendsen L; Stürzebecher J
    Thromb Haemost; 1997 Mar; 77(3):498-503. PubMed ID: 9066001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary structure of bovine plasma high-molecular-weight kininogen. Characterization of carbohydrate-free fragment 1.2 (fragment X) released by the action of plasma kallikrein and its biological activity.
    Han YN; Kato H; Iwanaga S; Oh-Ishi S; Katori M
    J Biochem; 1978 Jan; 83(1):213-21. PubMed ID: 564343
    [No Abstract]   [Full Text] [Related]  

  • 40. Estimation of the possible recognition sites for thrombomodulin, procoagulant, and anticoagulant proteins around the active center of alpha-thrombin.
    Nishioka J; Taneda H; Suzuki K
    J Biochem; 1993 Jul; 114(1):148-55. PubMed ID: 8407867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.